Myung Jin Son

national institute of food and drug safety evaluation

H指数:28

被引数:4,292

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liver organoids for chemical risk assessment: biological fidelity, standardization, and context-of-use frameworks

肝类器官用于化学风险评估：生物保真度、标准化和用途框架

Archives of Pharmacal Research

IF7.5

2026-06-180

PRE

A human liver organoid platform for hepatotoxicity assessment: evaluation using reference compounds

用于肝毒性评估的人类肝脏类器官平台：参考化合物的评估

Frontiers in Toxicology

IF4.6

2026-06-010

Synergistic enhancement of AAV gene delivery in 2D cells and 3D organoids using polybrene and hydroxychloroquine

联合使用聚brene和羟基氯喹在2D细胞和3D类器官中协同增强AAV基因递送

PLOS ONE

IF2.6

2025-11-140

PRE

Piperidinesulfonyl derivatives, novel CYP4A inhibitors, ameliorate hepatic lipotoxicity in metabolic dysfunction-associated steatotic liver disease

哌啶磺酰基衍生物，新型的CYP4A抑制剂，可改善代谢功能障碍相关脂肪性肝病中的肝脂毒性。

Biochemical Pharmacology

IF5.6

2025-11-050

PRE

Single-cell eQTL analysis identifies genetic variation underlying metabolic dysfunction-associated steatohepatitis

单细胞eQTL分析确定代谢功能障碍相关脂肪性肝炎的遗传变异

Nature Genetics

IF0

2025-06-250

PRE

Hepatotoxicity evaluation method through multiple-factor analysis using human pluripotent stem cell derived hepatic organoids

使用人类多能干细胞衍生的肝类器官通过多因素分析进行的肝毒性评估方法

SCIENTIFIC REPORTS

IF3.9

2025-03-280

OAAI

Helicobacter pylori VacA-induced mitochondrial damage in the gastric pit cells of the antrum and therapeutic rescue

BIOMATERIALS

IF12.9

2025-03-010

OAAI

Local Stiffness Measurement of Hepatic Steatosis Model Liver Organoid by Fluorescence Imaging-Assisted Probe Indentation

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2024-11-190

PRE

Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction-associated fatty liver disease

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-10-040

OAAI

Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation

TOXICS

IF4.1

2024-05-170

OAAI

Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for disease modeling

SCIENTIFIC REPORTS

IF3.9

2023-12-224

OAAI

A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression

HEPATOLOGY

IF15.8

2023-11-167

PRE

In vitro modeling of liver fibrosis with 3D co-culture system using a novel human hepatic stellate cell line

使用新型人肝星状细胞系的3D共培养系统对肝纤维化进行体外建模

BIOTECHNOLOGY AND BIOENGINEERING

IF3.6

2023-01-2210

Advances in liver organoids: model systems for liver disease

ARCHIVES OF PHARMACAL RESEARCH

IF7.5

2022-06-0411

PRE

The development of a functional human small intestinal epithelium model for drug absorption

SCIENCE ADVANCES

IF12.5

2021-06-0440

PREAI

Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids

CELLS

IF5.2

2021-01-1118

OAAI

Homeoprotein Msx1-PIASy Interaction Inhibits Angiogenesis

CELLS

IF5.2

2020-08-078

OAAI

Optimization of 3D hydrogel microenvironment for enhanced hepatic functionality of primary human hepatocytes

BIOTECHNOLOGY AND BIOENGINEERING

IF3.6

2020-04-0815

PREAI

Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids

可扩展的人类多能干细胞衍生的肝细胞样肝类器官的产生

JOURNAL OF HEPATOLOGY

IF33

2019-11-01206

PREAI

Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model

JOURNAL OF BIOLOGICAL ENGINEERING

IF6.5

2019-08-0815

OAAI

Myung Jin Son

个人简介

教育背景

工作经历

荣誉奖项

研究方向